Immunovant Inc (NASDAQ:IMVT)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IMVT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IMVT

  • Market Cap$1.100bn
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS45258J1025

Company Profile

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).

Latest IMVT news

Currently there for this company. Visit our news hub for other news .